ursolic acid has been researched along with Astrocytoma, Grade IV in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Deng, G; Li, Y; Liu, B; Song, P; Zhao, L; Zhao, Q; Zhou, L; Zhou, Y | 1 |
Huang, BR; Liao, PJ; Lu, CC; Yen, GC | 1 |
Jiang, C; Li, Y; Wang, J; Wang, X | 1 |
3 other study(ies) available for ursolic acid and Astrocytoma, Grade IV
Article | Year |
---|---|
Ursolic acid nanoparticles for glioblastoma therapy.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Mice; Nanoparticles; Ursolic Acid | 2023 |
Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Cyclophilins; Cyclosporine; DNA Damage; Glioblastoma; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Peptidyl-Prolyl Isomerase F; Reactive Oxygen Species; Signal Transduction; Triterpenes; Ursolic Acid | 2014 |
Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans; MicroRNAs; Real-Time Polymerase Chain Reaction; RNA-Binding Proteins; Signal Transduction; Transforming Growth Factor beta1; Triterpenes; Ursolic Acid | 2012 |